FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma (2024)
- Authors:
- USP affiliated authors: GARCIA, CRISTIANA BERNADELLI - FCFRP ; SOUSA, LUCAS OLIVEIRA - FCFRP ; LOPES, NORBERTO PEPORINE - FCFRP ; ALMEIDA, LUCIANA OLIVEIRA DE - FCFRP ; LEOPOLDINO, ANDRÉIA MACHADO - FCFRP ; USHIDA, TATIANE RESENDE - FCFRP ; SILVA, GABRIEL DA - FCFRP ; ALVES, JOVELINA SAMARA FERREIRA - FCFRP ; POTENZA, JULIA - FCFRP
- Unidade: FCFRP
- DOI: 10.1111/jop.13498
- Subjects: APOPTOSE; CARCINOMA DE CÉLULAS ESCAMOSAS; FARMACOTERAPIA; ANTINEOPLÁSICOS; NEOPLASIAS DE CABEÇA E PESCOÇO; NEOPLASIAS BUCAIS
- Keywords: Autophagy; Cisplatin resistance; Fingolimod; Paclitaxel; Sphingolipid
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal Of Oral Pathology & Medicine
- ISSN: 0904-2512
- Volume/Número/Paginação/Ano: v. 53, n. 1, p. 42-52, 2024
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TORRES, Lizeth Andrea Torres et al. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma. Journal Of Oral Pathology & Medicine, v. 53, n. 1, p. 42-52, 2024Tradução . . Disponível em: https://doi.org/10.1111/jop.13498. Acesso em: 30 dez. 2025. -
APA
Torres, L. A. T., Silva, G. da, Alves, J. S. F., Ushida, T. R., Potenza, J., Garcia, C. B., et al. (2024). FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma. Journal Of Oral Pathology & Medicine, 53( 1), 42-52. doi:10.1111/jop.13498 -
NLM
Torres LAT, Silva G da, Alves JSF, Ushida TR, Potenza J, Garcia CB, Sousa LO, Lopes NP, Almeida LO de, Leopoldino AM. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma [Internet]. Journal Of Oral Pathology & Medicine. 2024 ; 53( 1): 42-52.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1111/jop.13498 -
Vancouver
Torres LAT, Silva G da, Alves JSF, Ushida TR, Potenza J, Garcia CB, Sousa LO, Lopes NP, Almeida LO de, Leopoldino AM. FTY720 increases paclitaxel efficacy in cisplatin‐resistant oral squamous cell carcinoma [Internet]. Journal Of Oral Pathology & Medicine. 2024 ; 53( 1): 42-52.[citado 2025 dez. 30 ] Available from: https://doi.org/10.1111/jop.13498 - Spermidine suppresses oral carcinogenesis through autophagy induction, DNA damage repair, and oxidative stress reduction
- SET protein modulates H4 histone methylation status and regulates miR-137 level in oral squamous cell carcinoma
- Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma
- Autoantibodies against set protein as a potential serum marker in cervical, breast and head and neck cancer patients: detection by ELISA assay
- The participation of tumor residing pericytes in oral squamous cell carcinoma
- Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma
- How do sphingolipids play a role in epigenetic mechanisms and gene expression?
- Accumulated SET protein up-regulates and interacts with hnRNPK, increasing its binding to nucleic acids, the Bcl-xS repression, and cellular proliferation
- SET overexpression in HEK293 cells regulates mitochondrial uncoupling proteins levels within a mitochondrial fission/reduced autophagic flux scenario
- SET oncoprotein accumulation regulates transcription through DNA demethylation and histone hypoacetylation
Informações sobre o DOI: 10.1111/jop.13498 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003246541.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
